Imperial College London

Dr Beata Wojciak-Stothard

Faculty of MedicineDepartment of Medicine

Senior Lecturer



+44 (0)20 7594 6821b.wojciak-stothard




535ICTEM buildingHammersmith Campus




Research Focus

The research focus of my group is to understand the mechanism of endothelial dysfunction in pulmonary hypertension. The objective of this work is to develop new therapeutic strategies for treatment of this disease. To achieve this we use data from proteomic, genomic and metabolomic screening of pulmonary hypertensive patient samples available in our Centre. This allows us to identify signalling mediators linked to endothelial dysfunction. We also manipulate the expression levels and activity of selected protein targets in cultured pulmonary vascular cells in order to verify their role in pulmonary vascular remodelling.

Drawing inspiration from advances in computer processing, our group together with the group of Professor Joshua Edel (Department of Chemistry, ICL), have produced pulmonary artery-ona-chip, a three dimensional model of a living, muscularised human lung blood vessel on a microchip.

YouTube placeholder

The device contains a series of microscopic chambers separated by a thin porous membrane. Endothelial cells are grown on one side and smooth muscle cells on the other. Nutritious medium is continuously pumped over the endothelial cells, effectively mimicking the flow of blood inside a vessel. By taking blood and cells from pulmonary hypertensive patients, we aim to recreate disease conditions inside the microchip. The device also aims to create a highly controlled environment for multiple drug testing and reduce, or even eliminate, the experimental use of animals. 


Our group was first to demonstrate that deficiency of oxygen and nitric oxide is a key factor in the disease process, inducing pulmonary endothelial barrier dysfunction and abnormal angiogenic responses as a result of an imbalance in the activation of actin cytoskeleton regulators, Rho GTPases: RhoA and Rac1. 

We have recently identified another Rho GTPase, RhoB which is involved in pulmonary vascular remodeling. RhoB regulates actin polymerisation and the intracellular trafficking of growth factor receptors in pulmonary endothelial and smooth muscle cells. Prenylation (the addition of hydrophobic molecules, farnesyl or a geranyl-geranyl moiety to the C-terminal cysteine(s) of the target protein) of RhoB is required for its membrane localization and activation. Interrupting this process could be helpful in a clinical setting: we are currently investigating the use of prenylation inhibitors in the treatment of pulmonary hypertension.  

Other projects centre around four main areas: (a) the role of chloride channel proteins (CLIC) in endothelial dysfunction in pulmonary hypertension; (b) therapeutic targeting of enzymes increasing nitric oxide bioavailability, DDAH; (c) role of neutrophils in pulmonary endothelial and smooth muscle activation and vascular remodelling in pulmonary hypertension; (d) endothelium-derived microparticles in pulmonary hypertension.

Fig 2

Figure 2.

 CLIC4 regulates angiogenic responses in human pulmonary artery endothelial cells. Cells were cultured in normoxic conditions or were exposed to hypoxia (2% oxygen) for 18 h. The cells were over expressing CLIC4 (AdCLIC4) or CLIC4 shRNA, as indicated; Matrigel tube assay. Bar=100 µm.

fig 3

Figure 3.

Pathways affecting RhoA activity in pulmonary vasculature (Wojciak-Stothard B Postgrad Med J. 2008 Jul;84(993):348-53)



Research Group

show research

Pulmonary Vascular Biology Group

PhD Students:

Lucio Iannone;

Lulwah Aldabbous;

Lisa Storck (primary supervisor: Dr Ed Tate from Chemistry Department);


Dr Vahitha Abdul-Salam;

Dr Lucie Duluc ;


If you are interested in joining my research group, please contact me by email ( ), enclosing a CV, short description of your research experience to date and proposed source of funding  for your work (if applicable).






Professor Hans-Joachin Schnittler, Institute of Anatomy and Vacular Biology, Munster University, Germany, 2005

Dr James Leiper, MRC Clinical Sciences Centre, Imperial College London, DDAH, vascular biology, nitric oxide, 2006 - 2016

Professor Jane Mitchell, Department of Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College, vascular biology, 2011 - 2016

Professor C Bernabeu, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040, Madrid, Spain., endoglin, vascular biology, 2014 - 2016

Professor John C Edwards, Department of Internal Medicine, St. Louis University, St. Louis MO, 2012 - 2016

Professor Kurt Stenmark, University of Colorado Denver Health Sciences Center, Aurora, 2012 - 2016

Professor Stuart Yuspa, Centre for Cancer Research, Bethesda, MD, USA, chloride intracellular channel proteins, 2012 - 2016

Mark Toshner, Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Foundation Trust, Papworth, Everard Cambridge, United Kingdom, vascular biology, 2013 - 2017

Guest Lectures

Role of chloride intracellular channel protein 4 in pulmonary vascular remodeling, 10th World Congress for Microcirculation, Kyoto, Japan, 2015

International CLIC4 meeting guest lecture:, Centre for Cancer Research, Bethesda, MD, USA, 2015

Rho GTPases in the regulation of endothelial function, Nencki Institute, Polish Academy of Sciences, Warsaw, Poland, 2012

RhoB is the regulation of endothelial dysfunction in pulmonary hypertension. Cardiovascular Biology Seminars., Clinical School, Cambridge University, 2013

Rho GTPases in the regulation of pulmonary vascular function, 6th European Vascular Biology Meeting, 2011

Cardiovascule Medicine Seminar Series: Rho GTPases in endothelial responses to hypoxia, King's College London, 2006

Regulation of endothelial polarity and migration under shear stress, Cell Motility Club, LMCB, UCL, 2003

Vascular endothelium: Role in disease pathogenesis and as a terapeutic agent: Rho GTPases in the regulation of endothelial function, Imperial College London Vascular Biology Symposium, 2008

Rho GTpases in endotelial responses to hypoxia, Grover Conference on Pulmonary Circulation, Denver, Colorado, 2006

Hypoxia, ischaemia and infarction: An Update. Cellular mechanisms underlying hypoxic damage., Fellowship of Postgraduate Medicine. Medical Society of London., 2007

Research Staff






Research Student Supervision

Sindi,H, Therapeutic role of exosome-mediated gene delivery in pulmonary hypertension (PH)

Aldabbous,L, The Role of Neutrophil Extracellular Traps (NETs) in the pathogenesis of Pulmonary Hypertension (PH)


Storck,L, Profiling Protein Prenylation Using a Quantitative Chemical Proteomics Approach


Topp,SF, The effect of Tipifarnib on VEGF-induced pulmonary endothelial angiogenesis

Belik,D, Endoglin+ endothelium-derived microparticles in endothelial dysfunction in pulmonary hypertension

Dagalan,D, Microparticles and endothelial dysfunction in pulmonary hypertension

Yixing,W, Role of RhoB in the Regulation of Pulmonary Endothelial Responses to Hypoxia

Redpath,A, cGMP in the regulation of pulmonary endothelial function

Panesar,J, The Role of NETs in Pulmonary Endothelial Dysfunction: a potential player in the pathogenesis of PH

Chohan,V, The effects of RhoB prenylation modification on pulmonary artery endothelial cells exposed to hypoxia

Dain,K, The role of Chloride Intracellular Channel 4 in the regulation of leukocyte adhesion to the pulmonary endothelium

Valencia,D, The role of chloride intracellular channel 4 in nuclear factor kappa B- mediated inflammation in Pulmonary Arterial hypertension

Thanighan,K, Potential therapeutic intervention for pulmonary hypertension — making cells talk to each other

Liu,WK, The role of RhoA-induced microparticles in the regulation of pulmonary endothelial function in vitro

Syed,A, RhoB in regulation of pulmonary endothelial cell responses to hypoxia